The premise behind the network is deceptively simple: nearly every inventor can point to someone who changed their trajectory. It might be a friend who challenged them to think bigger, a teacher who recognized their potential early, a colleague who opened a door at a critical moment, or a leader who invested in their success. Those mentors, the academy argues, help shape careers, drive the discovery of new technologies, and ultimately improve lives. By formalizing that mentorship impulse into a national network, the organization hopes to scale a dynamic that has historically operated informally, one relationship at a time, across laboratories, classrooms, and companies.

The National Invention Ambassadors Network brings together an unusually broad coalition of American innovation leadership. Its inaugural cohort includes accomplished inventors, entrepreneurs, researchers, scientists, engineers, university leaders, industry executives, intellectual property experts, and innovation leaders drawn from across the United States. Collectively, the members represent the full breadth of American innovation, spanning higher education, industry, and government, as well as healthcare and life sciences, national security and defense, advanced manufacturing, aerospace, energy, artificial intelligence, and emerging technologies. The academy emphasizes that the ambassadors together reflect the people, places, disciplines, and sectors driving invention and innovation across the country, a deliberate design choice intended to ensure that the network’s reach extends well beyond any single field or region.

The initiative has drawn explicit endorsement from the federal government. John A. Squires, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, said that the network will expand opportunities by inspiring future generations of innovators on the frontiers of today’s discoveries. He added that the USPTO is proud to partner with the National Academy of Inventors to strengthen the nation’s economic competitiveness through the renewal and transformation of American inventiveness into innovations that improve lives and create prosperity. The statement underscores the patent office’s long-standing interest in cultivating a deeper public understanding of intellectual property, which officials view as a foundation for sustained technological and economic leadership.

According to the academy, America’s inaugural National Invention Ambassadors have already built companies, advanced scientific discovery, strengthened public institutions, transformed industries, and launched countless careers. Through the new initiative, they will take on a defined set of responsibilities. They will champion intellectual property education and innovation literacy while mentoring students, researchers, faculty, entrepreneurs, and inventors. They will inspire and help build the next generation of inventors through keynote presentations, workshops, and educational programming. They will work to strengthen technology commercialization practices while fostering collaboration among universities, industry, government, investors, and nonprofit organizations. And they will support regional innovation ecosystems and America’s broader economic competitiveness, connecting local invention communities to national resources and networks.

The emphasis on mentorship as a technical and strategic practice, rather than a vague aspiration, is central to how the network describes itself. Dr. James Conley, a Charter Fellow of the National Academy of Inventors, a National Invention Ambassador, and Clinical Professor of Operations at Northwestern University, said that most inventor journeys are shaped by mentors who share their experience, challenge assumptions, open doors, and create opportunities. He described the network as a meaningful way to help others navigate the path from discovery to impact. That framing reflects a growing recognition in innovation policy that the gap between a laboratory discovery and a market-ready product is rarely closed by technical skill alone; it requires institutional knowledge, legal and financial literacy, and access to experienced guides who have made the journey before.

Technology commercialization, one of the network’s stated focus areas, sits at the heart of that challenge. Universities and federal laboratories produce a steady stream of patented discoveries, yet translating those discoveries into licensed technologies, startups, and products demands coordination among technology transfer offices, investors, industry partners, and regulatory bodies. By deploying ambassadors who have personally navigated patenting, licensing, and company formation, the academy aims to strengthen those practices and reduce the friction that causes promising inventions to stall. The network’s composition, which deliberately includes intellectual property experts alongside inventors and executives, suggests an approach that treats the legal and commercial dimensions of innovation as inseparable from the scientific ones.

The National Academy of Inventors is positioning the network as an open invitation rather than a closed club. The organization is calling on universities, federal agencies, corporations, foundations, entrepreneurs, investors, innovation organizations, and individual innovators to become part of what it describes as a growing national movement. The academy maintains a public roster of ambassadors at its website, where organizations can also request ambassador participation in events and learn more about the NAI-USPTO Joint Project. That accessibility is likely to matter for regional institutions and smaller organizations that lack the internal mentorship infrastructure of large research universities but stand to benefit most from connection to a national pool of experienced inventors.

Dr. Paul R. Sanberg, President of the National Academy of Inventors and Distinguished Professor at the University of South Florida, framed the initiative in terms of legacy. The legacy of any inventor, he said, is more than just the intellectual property and technology they create; it includes the people they inspire, mentor, and prepare to achieve great things. Through the National Invention Ambassadors Network, he argued, everyone has the opportunity to engage America’s leading innovators, invest in the next generation, and ensure an enduring benefit to society. The statement reflects the academy’s broader mission, which centers on recognizing and encouraging inventors with U.S. patents, enhancing the visibility of academic technology and innovation, encouraging the disclosure of intellectual property, and convening partnerships that accelerate the translation of discovery into societal and economic impact.

The network’s launch also signals more to come from the academy’s partnership with the federal patent office. In the coming months, the National Academy of Inventors says it will introduce additional initiatives under its Joint Project Agreement with the USPTO that create new opportunities to connect America’s leading inventors with federal agencies, strategic partners, and mission-driven innovation initiatives. The academy, a member organization comprising U.S. and international universities, governmental agencies, and nonprofit research institutes, counts more than 4,600 individual inventor members and Fellows representing over 300 institutions worldwide. With that scale behind it, the Ambassadors Network represents a test of whether structured, national-scale mentorship can measurably strengthen the pipeline that carries American discoveries from the bench to the marketplace, and whether the country’s most accomplished inventors, given a formal platform, can multiply their impact through the people they prepare to follow them.

Subject of Research: A national inventor mentorship network launched by the National Academy of Inventors in partnership with the USPTO to strengthen innovation education and technology commercialization in the United States.

Article Title: The National Academy of Inventors launches the National Invention Ambassadors Network, expanding work under joint project agreement with USPTO

Article References: The National Academy of Inventors launches the National Invention Ambassadors Network, expanding work under joint project agreement with USPTO. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: National Academy of Inventors, USPTO, National Invention Ambassadors Network, innovation, mentorship, intellectual property, technology commercialization, entrepreneurship, inventors, economic competitiveness, STEM education, research universities

The fiscal backdrop gives the findings particular urgency. The FY2027 President’s Budget Request proposed cutting the National Institutes of Health by 12 percent, roughly $5 billion, and reducing the National Science Foundation by more than half, alongside a 15 percent cap on NIH indirect cost rates, a figure far below the 50 to 60 percent rates most research universities negotiate. With final FY2027 appropriations deferred until after the midterm elections, science agencies are operating on a stopgap basis, leaving institutions uncertain about their federal funding outlook. Against that uncertainty, the Cure analysis offers a data-driven map of how universities can diversify, and it arrives with a genuinely surprising conclusion: there is no single blueprint for successful industry engagement.

The analysis identified four distinct pathways through which universities engage industry: scientific collaboration, industry-sponsored clinical research, small-business partnerships, and entrepreneurial training. On the first two pathways, the expected hierarchy holds, and the highest-ranked universities lead. Top-decile institutions publish papers with industry collaborators at rates more than twice those of bottom-decile universities, with 8.9 percent of publications at top-decile schools involving industry co-authors compared with 3.5 percent at bottom-decile institutions. Leading universities also attract higher levels of industry participation in clinical trials, with industry-sponsored trials accounting for 24.5 percent of trial activity among top-decile universities versus 19.0 percent among bottom-decile institutions. Notably, that clinical trial gap is far narrower than the co-authorship gap, an early indication that industry engagement is not confined to elite institutions.

On the other two pathways, the conventional ranking story reverses entirely. Through the federal Small Business Technology Transfer program, bottom-decile universities earn STTR awards at a rate of 0.82 per $10 million in research funding, against 0.18 for top-decile institutions, a rate more than four times higher. Data from the National Science Foundation’s Innovation Corps program show a similar inversion: while top-ranked universities are more likely to participate in I-Corps overall, lower-ranked universities earn I-Corps awards at more than five times the rate per research dollar, 0.83 versus 0.15 per $10 million. In practical terms, institutions outside the traditional research elite are building commercialization engines through entrepreneurship and small-business collaboration at a pace that their better-funded peers have not matched.

The scale of the divergence is striking when expressed in absolute terms. Bottom-decile institutions form small-business research partnerships at more than four times the rate of top-decile universities per research dollar, and they earn federal entrepreneurship-training awards at more than five times the rate. Perhaps the most dramatic individual example is the University of Texas Health Science Center at Tyler, ranked 184th overall on the Cure Innovation Index. That institution runs nearly nine out of every 10 of its clinical trials with an industry partner, about three and a half times the rate of the top-ranked decile, working across 13 pharmaceutical and biotech partners with a portfolio concentrated in oncology and hematology. Its performance illustrates the central finding of the analysis: meaningful industry engagement can emerge far beyond the universities that traditionally dominate discussions about research excellence and innovation.

Standout performers appear at every tier of the rankings, and the analysis suggests they follow recognizably different models. The University of California, San Diego, ranked seventh, and the University of Pennsylvania, ranked third, exemplify what might be called the elite research partnership model, combining strong overall performance with deep industry engagement through scientific collaboration and industry-sponsored clinical research. UC San Diego recorded industry co-authorship at 11.1 percent of publications and industry sponsorship on 30.2 percent of its 543 assessed trials, while Penn posted 8.8 percent co-authorship and 23.3 percent industry sponsorship across 754 trials. Both institutions demonstrate that the traditional strengths of flagship research universities translate directly into industry appeal for large-scale scientific and clinical collaboration.

A different model emerges among mid-ranked institutions that have invested heavily in entrepreneurial infrastructure. The University of Connecticut, ranked 99th, and the University of Georgia, ranked 118th, outperform many higher-ranked peers in industry-facing entrepreneurial activity and small-business partnerships. UConn earned STTR awards at a rate of 0.64 per $10 million in research funding and recorded industry sponsorship on 24.7 percent of its 81 assessed trials, while Georgia posted an STTR rate of 0.66 per $10 million. Both figures substantially exceed the rates achieved by top-decile universities, showing that commercialization strength is not limited to the highest-ranked research universities and that deliberate investment in technology transfer and startup support can yield measurable industry engagement even without an elite research portfolio.

The implications run in both directions. For pharmaceutical, biotech, and other industry organizations seeking university partners, the analysis suggests that institutional reputation alone is a poor proxy for fit. Seema Kumar, CEO of Cure, the healthcare innovation ecosystem headquartered in New York City, noted that a company seeking large-scale clinical research may find its best fit at a university with an affiliated medical center, while one looking for entrepreneurial partnerships may find stronger opportunities at an institution with deep startup and technology-transfer support. In other words, the optimal partner depends on the objective, and the data now exist to make that match systematically rather than by reputation.

For universities themselves, Kumar emphasized that the analysis offers an equally important lesson: there is no single path to successful industry engagement. Institutions can build meaningful partnerships by leaning into their particular strengths rather than trying to replicate a single model borrowed from the most famous research universities. A specialized health science center in East Texas and a flagship land-grant university in Georgia are demonstrating that focused strategies, whether concentrated clinical trial operations in oncology or aggressive pursuit of small-business technology transfer awards, can generate industry revenue and research opportunities that partially insulate institutions from federal funding volatility. What surprised the Cure team, Kumar said, is that some universities excel in clinical research and scientific collaboration while others build powerful commercialization engines through entrepreneurship, and in some cases institutions outside the traditional elite may have lessons to teach the rest of the sector.

The analytical foundation behind these findings is itself notable. The Cure Innovation Index, launched in April 2026, evaluates 25 indicators across three core domains: Research Capabilities, Entrepreneurial Readiness, and Market Translation. It ranks the top 303 academic institutions, comprising 243 universities and 60 institutes and centers, from a field of more than 6,000 nationwide, and provides peer-benchmarked comparisons along with customized improvement recommendations. The methodology integrates validated data from more than a dozen federal and commercial databases, including the National Science Foundation’s Higher Education Research and Development Survey and Dimensions, an interlinked research information system provided by Digital Science. By normalizing partnership metrics against institutional research funding, the index reveals patterns of engagement that raw dollar figures would obscure, and it is precisely those normalized comparisons that expose the unexpected strength of lower-ranked institutions. As federal appropriations remain unresolved and universities confront the prospect of sustained funding pressure, the analysis suggests that the most resilient institutions of the coming decade may be those that treat industry not as a supplementary revenue stream but as a structural partner, and that discover, as the data show, that the door to such partnership is open far wider than the rankings imply.

Subject of Research: University-industry research partnerships as an alternative funding pathway for U.S. biomedical research institutions

Article Title: Industry partnerships offer new opportunities for universities amid federal funding pressures

Article References: Industry partnerships offer new opportunities for universities amid federal funding pressures. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: university-industry partnerships, biomedical research funding, Cure Innovation Index, NIH budget cuts, clinical trials, STTR program, I-Corps, technology transfer, translational science, entrepreneurship, research universities, pharmaceutical industry